Pituitary cytokine and growth factor expression and action

Endocrine Reviews

Volumn 18, Issue 2, 1997, Pages 206-228

  Ray, David ^a   Melmed, Shlomo ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ANGIOTENSIN; CYTOKINE; ENDOTHELIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; FOLLISTATIN; GALANIN; GROWTH FACTOR; INHIBIN; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; NERVE GROWTH FACTOR; PARATHYROID HORMONE RELATED PROTEIN; SOMATOMEDIN B; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ADENOHYPOPHYSIS; GENE EXPRESSION REGULATION; GROWTH HORMONE RELEASE; HUMAN; HYPOPHYSIS TUMOR; IMMUNOMODULATION; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEPTIC SHOCK;

EID: 0030999191     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/edrv.18.2.0297     Document Type: Review

References (357)

1. Rosenfeld MG, Bach I, Erkman L, Li P, Lin C, Lin S, McEvilly R, Ryan A, Rhodes S, Schonnemann M, Scully K 1996 Transcriptional control of cell phenotypes in the neuroendocrine system. Recent Prog Horm Res 51:217-239
2. Mangalam HJ, Albert VR, Ingraham HA, Kapiloff M, Wilson L, Nelson C, Elsholtz H, Rosenfeld MG 1989 A pituitary POU domain protein, Pit-I, activates both growth hormone and prolactin promoters transcriptionally. Genes Dev 3:946-958
3. Horn F, Windle JJ, Barnhart KM, Mellon PL 1992 Tissue-specific gene expression in the pituitary: the glycoprotein hormone alpha-subunit gene is regulated by a gonadotrope specific protein. Mol Cell Biol 12:2143-2153
4. Theill LE, Karin M 1993 Transcriptional control of GH expression and anterior pituitary development. Endocr Rev 14:670-689
5. Woodruff TK, Mather JP 1995 Inhibin, activin and the female reproductive axis. Annu Rev Physiol 57:219-244
6. Ackland JF, Schwartz NB, Mayo KE, Dodson RE 1992 Nonsteroidal signals originating in the gonads. Physiol Rev 72:731-787
7. Dinarello CA 1985 An update on human interleukin-1: from molecular biology to clinical relevance. J Clin Immunol 5:287-297
8. Thorner MO, Vance ML, Evans WS, Blizzard RM, Rogol AD, Ho K, Leong DA, Borges JL, Cronin MJ, MacLeod RM, Kovacs K, Asa S, Horvath E, Frohman L, Furlanetto R, Klingensmith GJ, Brook C, Smith P, Reichlin S, Rivier J, Vale W 1986 Physiological and clinical studies of GRF and GH. Recent Prog Horm Res 42:589-640
9. Wehrenberg WB, Baird A, Zeytin F, Esch F, Bohlen P, Ling N, Ying SY, Guillemin R 1985 Physiological studies with somatocrinin, a growth hormone-releasing factor. Annu Rev Pharmacol Toxicol 25:463-483
10. Mayo KE 1992 Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone. Mol Endocrinol 6:1734-1744
11. Orth DN 1992 Corticotroph-releasing hormone in humans. Endocr Rev 13:164-191
12. Rivier J, Spiess J, Vale W 1983 Characterization of rat hypothalamic corticotropin-releasing factor. Proc Natl Acad Sci USA 80: 4851-4855
13. Conn PM, Crowley Jr WF 1991 Gonadotropin-releasing hormone and its analogues. N Engl J Med 324:93-103
14. Straub RE, Frech GC, Joho RH, Gershengorn MC 1990 Expression cloning of a cDNA encoding the mouse pituitary thyrotropin-releasing hormone receptor. Proc Natl Acad Sci USA 87:9514-9518
15. Frohman LA, Jansson J-O 1986 Growth hormone-releasing hormone. Endocr Rev 7:223-253
16. Billestrup N, Swanson LN, Vale W 1986 Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. Proc Natl Acad Sci USA 83:6854-6857
17. Billestrup N, Mitchell RL, Vale W, Verma IM 1987 Growth hormone releasing factor induces c-fos expression in cultured primary pituitary cells. Mol Endocrinol 1:300-305
18. Halper J, Parnell PG, Carter BJ, Ren P, Scheithauer BW 1992 Presence of growth factors in human pituitary. Lab Invest 66:639-645
19. Thapar K, Kovacs K, Laws ER 1995 The classification and molecular biology of pituitary adenomas. Adv Tech Standards Neurosurg 22:3-53, 1995
20. Dinarello CA 1994 The biological properties of interleukin 1. Eur Cytokine Netw 5:517-531
21. Dinarello CA 1996 Biological basis for interleukin 1 in disease. Blood 87:2095-2147
22. Saklatvala J 1995 Intracellular signalling mechanisms of interleukin 1 and tumor necrosis factor: possible targets for therapy. Br Med Bull 51:402-418
23. Koenig JI, Snow K, Clark BD, Toni R, Cannon JG, Shaw AR, Dinarello CA, Reichlin S, Lee SL, Lechan RM 1990 Intrinsic pituitary interleukin-1 beta is induced by bacterial lipopolysaccharide. Endocrinology 126:3053-3058
24. Schneider JH, Hofman FM, Weiss MH, Hinton DR 1993 Cytokine expression in pituitary adenomas. Program of the 3rd International Pituitary Congress, Marina Del Rey, CA, MP-10
25. Cuningham ET, Wada E, Carter DB, Tracey DE, Battey JF, De Soya EB 1992 In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary and adrenal gland of the mouse. J Neurosci 12:1101-1114
26. 125I recombinant human interleukin 1 receptor antagonist. J Neuroimmunol 41:51-60
27. DeSouza EB, Webster EL, Grigoriadis DE, Tracey DE 1989 Corticotrophin-releasing factor (CRF) and interleukin-I (IL-1) receptors in the brain-pituitary-immune axis. Psychopharmacol Bull 25:299-305
28. Takao T, Culp SG, DeSouza EB 1993 Reciprocal modulation of interleukin 1beta and interleukin-I receptors by lipopolysaccharide (endotoxin) treatment in the mouse brain-endocrine-immune axis. Endocrinology 132:1497-1504
29. Bristulf J, Simoncsits A, Bartfai T 1991 Characterisation of a neuronal interleukin-1 receptor and the corresponding mRNA in the mouse anterior pituitary cell line AtT20. Neurosci Lett 128:173-176
30. Takao T, Dieterich KD, Tracey DE, DeSouza EB 1994 Cyclic AMP dependent modulation of interleukin-1 receptors in the mouse AtT20 pituitary tumor cell line. Brain Res 656:177-181
31. Parnet P, Brunke DL, Goujon E, Mainard JD, Biragyn A, Arkins S, Dantzer R, Kelley KW 1993 Molecular identification of two types of interleukin-I receptors in the murine pituitary gland. J Neuroendocrinol 5:213-219
32. French RA, Zachary J, Dantzer R, Frawley LS, Chizzonite R, Parnet P, Kelley KW 1996 Dual expression of p80 type I and p68 type II interleukin I receptors on anterior pituitary cells synthesizing growth hormone. Endocrinology 137:4027-4036
33. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC 1990 Interleukin-I receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336-340
34. Carter DB, Deibel Jr MR, Dunn CJ, Tomich CS, Laborde AL, Slightom JL, Berger AE, Bienkowski MJ, Sun FF, McEwan RN, Harris PKW, Yem AW, Waszak GA, Chosay JG, Sieu LC, Hardee MM, Zurcher-Neely HA, Reardon IM, Heinrikson RL, Truesdell SE, Shelly JA, Eesalu TE, Taylor BM, Tracey DE 1990 Purification, cloning, expression and biological characterization of an interleukin-I receptor antagonist protein. Nature 344:633-638
35. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC 1990 Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341-346
36. Dinarello CA, Thompson RC 1991 Blocking IL-1: interleukin 1 receptor anatagonist in vivo and in vitro. Immunol Today 12:404-410
37. Sauer J, Arzt E, Gumprecht H, Hopfner U, Stalla GK 1994 Expression of interleukin-1 receptor antagonist in human pituitary adenomas in vitro. J Clin Endocrinol Metab 79:1857-1863
38. Bernton EW, Beach JE, Holaday JW, Smallridge RC, Fein HG 1987 Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 238:652-654
39. Wassen FW, Moerings EP, Van Toor H, DeVrey EA, Henneman G, Everts ME 1996 Effects of interleukin-1 beta on thyrotropin secretion and thyroid hormone uptake in cultured rat anterior pituitary cells. Endocrinology 137:1591-1598
40. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W 1987 Interleukin-1 stimulates the secretion of hypothalamic corticotrophin-releasing factor. Science 238:522-524
41. Suda T, Tozawa F, Ushiyama T, Tomori N, Sumitomo T, Nakagami Y, Yamada M, Demura H, Shizume K 1989 Effects of protein kinase C related adrenocorticotrophin secretogogues and interleukin-I on proopiomelanocortin gene expression in rat anterior pituitary cells. Endocrinology 124:1444-1449
42. Boyle M, Yamamoto G, Chen M, Rivier J, Vale W 1987 Interleukin-I prevents loss of corticotrophic responsiveness to beta adrenergic stimulation in vitro. Proc Natl Acad Sci USA 85:5556-5560
43. Patterson JC, Childs GV 1994 Nerve growth factor in the anterior pituitary: regulation of secretion. Endocrinology 135:1697-1704
44. Robb RJ 1984 Interleukin-2: the molecule and its function. Immunol Today 5:203-209
45. Greene WC, Leonard WJ 1986 The human interleukin 2 receptor. Annu Rev Immunol 4:69-95
46. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I 1991 Development and function of T cells in mice rendered interleukin 2 deficient by gene targeting. Nature 352:621-624
47. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D 1994 Utilisation of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 13:2822-2830
48. Grabstein K, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM, Giri JG 1994 Cloning of a T cell growth factor that interacts with the beta chain of the interleukin 2 receptor. Science 264:965-968
49. Arzt E, Stelzer G, Renner U, Lange M, Muller OA, Stalla GK 1992 Interleukin-2 and interleukin 2 receptor expression in human corticotrophic adenoma and mouse pituitary cell cultures. J Clin Invest 90:1944-1951
50. Karanth S, McCann SM 1991 Anterior pituitary hormone control by interleukin 2. Proc Natl Acad Sci USA 88:2961-2965
51. Lotze MT, Frana LW, Sharrow SO, Robb RJ, Rosenberg SA 1985 In vivo administration of purified human interleukin 2. I. Half-life and immunologie effects of the Jurkat cell-line derived interleukin 2. J Immunol 134:157-166
52. Denicoff KD, Durkin TM, Lotze MT, Quinlan PE, Davis CL, Listwak SJ, Rosenberg SA, Rubinow DR 1989 The neuroendocrine effects of interleukin 2 treatment. J Clin Endocrinol Metab 69:402-410
53. Kishimoto T, Hirano T 1988 Molecular regulation of B lymphocyte response. Annu Rev Immunol 6:485-492
54. Snick JV 1990 Interleukin-6: an overview. Annu Rev Immunol 8:253-278
55. Kishimoto T, Taga T, Akira S 1994 Cytokine signal transduction Cell 76:253-262
56. Vankelecom H, Carmeliet P, Van Damme J, Billiau A, Denef C 1989 Production of interleukin-6 by folliculostellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system. Neuroendocrinology 49:102-106
57. Spangelo BL, MacLeod RM, Isakson PC 1990 Production of interleukin-6 by anterior pituitary cells in vitro. Endocrinology 126: 582-586
58. Jones TH, Justice S, Price A, Chapman K 1991 Interleukin-6 secreting human pituitary adenomas in vitro. J Clin Endocrinol Metab 73:207-209
59. Tsagarakis S, Kontogeorgos G, Giannou P, Thalassinos M, Woolley J, Besser GM, Grossman A 1992 Interleukin-6, a growth promoting cytokine, is present in human pituitary adenomas: an immunocytochemical study. Clin Endocrinol (Oxf) 37:163-167
60. Jones TH, Daniels M, James RA, Justice SK, McCorkle R, Price A, Kendall-Taylor P, Weetman AP 1994 Production of bioactive and immunoreactive interleukin-6 (IL-6) and expression of IL-6 messenger ribonucleic acid by human pituitary adenomas. J Clin Endocrinol Metab 78:180-187
61. Spangelo BL, Isakson PC, MacLeod RM 1990 Production of interleukin-6 by anterior pituitary cells is stimulated by increased intracellular adenosine 3′5′ monophosphate and vasoactive intestinal peptide. Endocrinology 127:403-409
62. Spangelo BL, Judd AM, MacLeod RM, Goodman DW, Isakson PC 1990 Endotoxin-induced release of interleukin-6 from rat medial basal hypothalami. Endocrinology 127:1779-1785
63. Spangelo BL, Jarvis WD, Judd AM, MacLeod RM 1991 Induction of interleukin-6 release by interleukin-1 in rat anterior pituitary cells in vitro: evidence for an eicosanoid-dependent mechanism. Endocrinology 129:2886-2894
64. Spangelo BL, Jarvis WD 1996 Lysophosphatidylcholine stimulates interleukin-6 release from rat anterior pituitary cells in vitro. Endocrinology 137:4419-4426
65. Muramami N, Fukata J, Tsukada T, Kobayashi H, Ebisui O, Segawa H, Muro S, Imura H, Nakao K 1993 Bacterial lipopolysaccharide-induced expression of interleukin-6 messenger ribonucleic acid in the rat hypothalamus, pituitary, adrenal gland and spleen. Endocrinology 133:2574-2578
66. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T 1989 Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58:573-581
67. Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T 1990 Molecular cloning of an IL-6 signal transducer, gp130. Cell 63:1149-1157
68. Sawada T, Koike K, Kanda Y, Ikegami H, Jikihara H, Maeda T, Osako Y, Hirota K, Miyake A 1995 Interleukin-6 stimulates cell proliferation of rat pituitary clonal cell lines in vitro. J Endocrinol Invest 18:83-90
69. Ohmichi M, Hirota K, Koike K, Kurachi H, Ohtsuka S, Matsuzaki N, Yamaguchi M, Miyake A, Tanizawa O 1992 Binding sites for interleukin 6 in the anterior pituitary gland. Neuroendocrinology 55:199-203
70. Spangelo BL, Judd AM, Isakson PC, MacLeod RM 1989 Interleukin-6 stimulates anterior pituitary hormone release in vitro. Endocrinology 125:575-577
71. Yamaguchi M, Matsuzaki N, Hirota K, Miyake A, Tanizawa O 1990 Interleukin-6 possibly induced by interleukin-β in the pituitary gland stimulates the release of gonadotrophins and prolactin. Acta Endocrinol (Copenh) 122:201-20556
72. Mastorakos G, Weber JS, Magiakou M-A, Gunn H, Chrousos GP 1994 Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metab 79:934-939
73. Fong Y, Moldawer LL, Marano M, Wei H, Tatter SB, Clarick RH, Santhanam U, Sherris D, May LT, Sehgal PB, Lowry SF 1989 Endotoxemia elicits increased circulating beta2-IFN/IL-6 in man. J Immunol 142:2321-2324
74. Arzt E, Buric R, Stelzer C, Stalla J, Sauer J, Renner U, Stalla GK 1993 Interleukin involvement in anterior pituitary cell growth regulation: effects of IL-2 and IL-6. Endocrinology 132:459-467
75. Tomida M, Yamamoto-Yamaguchi Y, Hozumi M 1984 Purification of a factor inducing differentiation of mouse myeloid leukemic M1 cells from conditioned medium of mouse fibroblast L929 cells. J Biol Chem 259:10978-10982
76. Metcalf D, Gearing DP 1989 Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc Natl Acad Sci USA 86:5948-5952
77. Escary JL, Perreau J, Dumenil D, Ezine S, Brulet P 1993 Leukemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature 363:361-364
78. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo JS 1992 Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature 359:76-79
79. Ferrara N, Winer N, Henzel WJ 1992 Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: identification as leukemia inhibitory factor. Proc Natl Acad Sci USA 89:698-702
80. Akita S, Webster J, Ren SG, Takino H, Said J, Zand O, Melmed S 1995 Human and murine pituitary expression of leukemia inhibitory factor: novel intrapituitary regulation of adrenocorticotrophin synthesis and secretion. J Clin Invest 95:1288-1298
81. Carter DA 1994 Expression of leukemia inhibitory factor/cholinergic differentiation factor is linked to adrenoceptor stimulation. Biochem Soc Trans 23:114S
82. Rathjen PD, Toth S, Willis A, Heath JK, Smith AG 1990 Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage. Cell 62:1105-1114
83. Wang Z, Ren SG, Melmed S 1996 Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface. Endocrinology 137:2947-2953
84. Stahl N, Yancopoulos G 1993 The alpha, beta and kinases of cytokine receptor complexes. Cell 74:587-590
85. Stefana B, Ray DW, Melmed S 1996 Leukemia inhibitory factor (LIF) induces differentiation of pituitary corticotroph function: a neuro-endocrine phenotypic switch. Proc Natl Acad Sci USA 93: 12502-12506
86. Ray DW, Ren SG, Melmed S 1996 Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J Clin Invest 97:1852-1859
87. Bousquet C, Ray D, Melmed S A common proopiomelanocortin binding element mediates leukemia inhibitory factor and corticotropin releasing hormone transcriptional synergy. J Biol Chem, in press
88. Akita S, Malkin J, Melmed S 1996 Disrupted murine leukemia inhibitory factor (LIF) gene attenuates adrenocorticotropic hormone (ACTH) secretion. Endocrinology 137:3140-3143
89. Bloom BR, Bennett B 1966 Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153:80-82
90. Mitchell R, Bacher M, Bernhagen J, Pushkarskaya T, Seidin MF, Bucala R 1995 Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J Immunol 154: 3863-3870
91. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A, Bucala R 1993 MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365:756-759
92. Calendra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R 1995 MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377:68-71
93. Bernhagen J, Calandra T, Cerami A, Bucala R 1994 Macrophage migration inhibitory factor is a neuroendocrine mediator of endotoxaemia. Trends Microbiol 2:198-201
94. Bernhagen J, Bacher M, Calandra T, Metz CN, Doty SB, Donnelly T, Bucala R 1996 An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med 183:277-282
95. Cohen S 1962 Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J Biol Chem 237:1555-1560
96. Carpenter G, Cohen S 1979 Epidermal growth factor. Annu Rev Biochem 48:193-216
97. Byyny RL, Orth DN, Cohen S 1972 Radioimmunoassay for epidermal growth factor. Endocrinology 90:1261-1266
98. Hirata Y, Orth DN 1979 Epidermal growth factor (urogastrone) in human tissues. J Clin Endocrinol Metab 48:667-672
99. Stoscheck CM, King Jr LE 1986 Role of epidermal growth factor in carcinogenesis. Cancer Res 46:1030-1037
100. Korc M, Padilla J, Grosso D 1986 Epidermal growth factor inhibits the proliferation of a human endometrial carcinoma cell line. J Clin Endocrinol Metab 62:874-880
101. Groenen LC, Nice EC, Burgess AW 1994 Structure-function relationships for the EGF/TGFα family of mitogens. Growth Factors 11:235-257
102. Kudlow JE, Kobrin MS 1984 Secretion of epidermal growth factor like mitogens by cultured cells from bovine anterior pituitary glands. Endocrinology 115:911-917
103. Halpern J, Hinkle PM 1983 Binding and internalization of epidermal growth factor by rat pituitary tumor cells. Mol Cell Endocrinol 33:183-196
104. Gourdji D, Tougard C, Texver-Vidal A 1982 Cloned prolactin strains as a tool in neuroendocrinology. In: Martini L, Ganong W (eds) Frontiers in Neuroendocrinology. Raven Press, New York, p 317
105. Chabot JG, Walker P, Pelletier G 1986 Distribution of epidermal growth factor binding sites in the adult rat pituitary gland. Peptides 7:45-50
106. Birman P, Michard M, Li JY, Peillon F, Bression D 1987 Epidermal growth factor-binding sites, present in normal human and rat pituitaries, are absent in human pituitary adenomas. J Clin Endocrinol Metab 65:275-281
107. LeRiche VK, Asa SL, Ezzat S 1996 Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness. J Clin Endocrinol Metab 81:656-662
108. Johnson LF, Baxter JD, Vlodavsky I, Gospodaowicz D 1980 Epidermal growth factor and expression of specific genes: effects of cultured rat pituitary are dissociable from the mitogenic response. Proc Natl Acad Sci USA 77:394-398
109. Schonbrunn A, Krasnoff M, Westendorf JM, Tashjian Jr AH 1980 Epidermal growth factor and thyrotrophin-releasing hormone act similarly on a clonal pituitary cell strain. Modulation of hormone production and inhibition of cell proliferation. J Cell Biol 85:786-797
110. Yajima Y, Saito T 1984 The effects of epidermal growth factor on cell proliferation and prolactin production by GH3 rat pituitary cells. J Cell Physiol 120:249-256
111. Felix R, Meza U, Cota G 1995 Induction of classical lactotropes by epidermal growth factor in rat pituitary cell cultures. Endocrinology 136:939-946
112. Murdoch GH, Potter E, Nicolaisen AK, Evans RM, Rosenfeld MG 1982 Epidermal growth factor rapidly stimulates prolactin gene transcription. Nature 300:192-194
113. Supowit SC, Potter E, Evans RM, Rosenfeld MG 1984 Polypeptide hormone regulation of gene transcription: specific 5′ genomic sequences are required for epidermal growth factor and phorbol ester regulation of prolactin gene expression. Proc Natl Acad Sci USA 81:2975-2979
114. Childs GV, Rougeau D, Unabia G 1995 Corticotropin-releasing hormone and epidermal growth factor: mitogens for anterior pituitary corticotropes. Endocrinology 136:1595-1602
115. Childs G, Patterson J, Unabia G, Rougeau D, Wu P 1991 Epidermal growth factor enhances ACTH secretion and expression of POMC mRNA by corticotropes in mixed and enriched cultures. Mol Cell Neurosci 2:235-243
116. Scoggins BA, Butkus A, Coghlan JP, Fei DTW, McDougall JG, Niall HD, Walsh JR, Wang X 1984 In vivo cardiovascular, renal and endocrine effects of epidermal growth factor in sheep. In: Labrie F, Proulx L (eds) Endocrinology. Proceedings of the 7th International Congress. Elsevier Science Publishers BV, Amsterdam, pp 573-576
117. Polk DH, Ervin MG, Padbury JF, Lam RW, Reviczky AL, Fisher DA 1987 Epidermal growth factor acts as a corticotrophin-releasing factor in chronically catheterised fetal lambs. J Clin Invest 79:984-988
118. Luger A, Calogero AE, Kalogeras K, Gallucci WT, Gold PW, Loriaux DL, Chrousos GP 1988 Interaction of epidermal growth factor with the hypothalamic-pituitary adrenal axis: potential physiologic relevance. Clin Endocrinol Metab 66:334-346
119. Missale C, Castelletti L, Boroni F, Memo M, Spano P 1991 Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell lines. Endocrinology 128:13-20
120. Rosenthal A, Linquist PB, Bringman TS, Goeddel DV, Derynck R 1986 Expression in rat fibroblasts of a transforming growth factor α cDNA results in transformation. Cell 46:301-309
121. Ignotz RA, Kelly B, Davis RJ, Massague J 1986 Biologically active precursor for transforming growth factor type alpha, released by retrovirally transformed cells. Proc Natl Acad Sci USA 83:6307-6311
122. Gentry LE, Twardzik DR, Lim GJ, Ranchalis JE, Lee DC 1987 Expression and characterisation of transforming growth factor precursor protein in transfected mammalian cells. Mol Cell Biol 7:1587-1591
123. Wong ST, Winchell IF, McCune BK, Earp HS, Teixido J, Massague J, Herman B, Lee DC 1989 The TGF alpha precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction. Cell 56:495-506
124. Bosenberg MW, Pandiella A, Massague J 1992 The cytoplasmic carboxy-terminal amino acid specifies cleavage of membrane TGF into soluble growth factor. Cell 71:1157-1165
125. Kudlow JE, Gerne BM 1983 Production of growth factor activity by cultured bovine calf anterior pituitary cells. Endocrinology 113: 104-110
126. Riss TL, Sirbasku DA 1989 Identification of a 15000 molecular weight form of immunoreactive transforming growth factor a in extracts of porcine pituitary. J Cell Physiol 138:393-404
127. Samsoondar J, Kobrin MS, Kudlow JE 1986 Alpha-transforming growth factor secreted by untransformed bovine anterior pituitary cells in culture. I. Purification from conditioned medium. J Biol Chem 261:14408-14413
128. Massague J 1990 Transforming growth factor alpha. A model for membrane anchored growth factors. J Biol Chem 265:21393-21396
129. Ju WD, Velu TJ, Vass WC, Papageorge AG, Lowy DR 1991 Tumorigenic transformation of NIH 3T3 cells by the autocrine synthesis of transforming growth factor-α. New Biol 3:380-388
130. Samsoondar J, Kobrin MS, Kudlow JE 1986 Alpha transforming growth factor secreted by untransformed bovine anterior pituitary cells in culture. I. Purification from conditioned medium. J Biol Chem 261:14408-14413
131. Kobrin MS, Samsoondar J, Kudlow JE 1986 Alpha transforming growth factor secreted by untransformed bovine anterior pituitary cells in culture. II. Identification using a sequence-specific monoclonal antibody. J Biol Chem 261:14414-14419
132. Kudlow JE, Leung AW, Kobrin MS, Paterson AJ, Asa SL 1989 Transforming growth factor alpha in the mammalian brain. Immunohistochemical detection in neurons and characterisation of its mRNA. J Biol Chem 264:3880-3883
133. Kobrin MS, Asa SL, Samsoondar J, Kudlow JE 1987 Alpha transforming growth factor in bovine anterior pituitary gland: secretion by dispersed cells and immunohistochemical localisation. Endocrinology 121:1412-1416
134. Al-Maatouq 1990 Transforming Growth Factor alpha Gene Expression in the Pituitary Gland. M.Sc. Thesis, University of Toronto, Toronto, Ontario, Canada
135. Finley EL, King JS, Ramsdell JS 1994 Human pituitary somatotrophs express transforming growth factor a and its receptor. J Endocrinol 141:547-554
136. Driman DK, Kobrin MS, Kudlow JE, Asa SL 1992 Transforming growth factor alpha in normal and neoplastic human endocrine tissues. Hum Pathol 23:1360-1365
137. Ezzat S, Walpola IA, Ramyar L, Smyth HS, Asa SL 1995 Membrane anchored expression of transforming growth factor alpha in human pituitary adenoma cells. J Clin Endocrinol Metab 80:534-539
138. Bordundvaag B, Kudlow JE, Mueller SG, George SR 1992 Dopamine receptor activation inhibits estrogen stimulated transforming growth factor alpha gene expression and growth in anterior pituitary, but not in uterus. Endocrinology 130:3453-3458
139. Saeki T, Cristiano A, Lynch MJ, Brattain M, Kim N, Normanno N, Kenney N, Ciardiello F, Salomon DS 1991 Regulation by estrogen through the 5′ flanking region of the transforming growth factor alpha gene. Mol Endocrinol 5:1955-1963
140. Mueller SG, Kobrin MS, Paterson AJ, Kudlow JE 1989 Transforming growth factor alpha expression in the anterior pituitary gland: regulation by epidermal growth factor and phorbol ester in dispersed cells. Mol Endocrinol 3:967-983
141. Mueller SG, Kudlow JE 1991 Transforming growth factor beta (TGF β) inhibits TGFa expression on bovine anterior pituitary-derived cells. Mol Endocrinol 5:1439-1446
142. Ramsdell JS 1991 Transforming growth factor alpha and beta are potent and effective inhibitors of GH4 rat pituitary cell proliferation. Endocrinology 128:1981-1990
143. Finley EL, Ramsdell JS 1994 A transforming growth factor alpha pathway is expressed in GH4C1 rat pituitary tumors and appears necessary for tumor formation. Endocrinology 135:416-422
144. McAndrew J, Paterson AJ, Asa SL, McCarthy KJ, Kudlow JE 1995 Targeting of transforming growth factor-α expression to pituitairy lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology 136:4479-4488
145. Mason IJ 1994 The ins and outs of fibroblast growth factors. Cell 78:547-552
146. Abraham JA, Mergia A, Whang JL, Tumolo A, Friedman J, Hjerrild KA, Gospodarowicz D, Fiddes JC 1986 Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 233:545-548
147. Gambarini AG, Armelin HA 1982 Purification and characterisation of an acidic fibroblast growth factor from bovine pituitary. J Biol Chem 257:9692-9697
148. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G 1987 Structural characterisation and biological functions of fibroblast growth factor. Endocr Rev 8:95-114
149. Gospodarowicz D 1974 Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 249:123-127
150. Osamu A, Yoshitake Y, Nishikawa K, Iseki S 1993 Immunocytochemical localisation of basic fibroblast growth factor in the rat pituitary gland. Arch Histol Cytol 56:269-276
151. Li Y, Koga M, Kasayama S, Matsumoto K, Arita N, Hayakawa T, Sato B 1992 Identification and characterization of high molecular weight forms of basic fibroblast growth factor in human pituitary adenomas. J Clin Endocrinol Metab 75:1436-1441
152. Silverlight JJ, Prysor-Jones RA, Jenkins JS 1990 Basic fibroblast growth factor in human pituitary tumours. Clin Endocrinol (Oxf) 32:669-676
153. Yaohua Li Koga M, Kasayama S, Matsumoto K, Arita N, Hayakawa T, Sato B 1992 Identification and characterization of high molecular weight forms of basic fibroblast growth factor in human pituitary adenomas. J Clin Endocrinol Metab 75:1436-1441
154. Ezzat S, Smyth HS, Ramyar L, Asa SL 1995 Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas. J Clin Endocrinol Metab 80:878-884
155. Elias KA, Weiner RI 1984 Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors. Proc Natl Acad Sci USA 81:4549-4553
156. Ferrara N, Schweigerer L, Neufeld G, Mitchell R, Gospodarowicz D 1987 Pituitary follicular cells produce basic fibroblast growth factor. Proc Natl Acad Sci USA 84:5773-5777
157. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold MC 1988 Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85-87
158. Friedman E, Sakaguchi K, Bale AE, Falchetti A, Streeten E, Zimering MB, Weinstein LS, McBride WO, Nakamura Y, Brandi ML, Norton JA, Aurbach GD, Spiegel AM, Marx SJ 1989 Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med 321:213-218
159. Thakker RV, Bouloux P, Wooding C, Chotai K, Broad PM, Spurr NK, Besser GM, O'Riordan JL 1989 Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 321:218-224
160. Thakker RV, Pook MA, Wooding C, Boscaro M, Scanarini M, Clayton RN 1993 Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest 91:2815-2821
161. Zimering MB, Katsumata N, Sato Y, Brandi ML, Aurbaeh GD, Marx SJ, Friesen HG 1993 Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1: relation to pituitary tumour. J Clin Endocrinol Metab 76:1182-1187
162. Zimering MB, Brandi ML, DeGrange DA, Marx SJ, Streeten E, Katsumata N, Murphy PR, Sato Y, Friesen HG, Aurbaeh GD 1990 Circulating fibroblast growth factor-like substance in familial multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 70:149-154
163. Zimering MB, Riley DJ, Thakker-Varia S, Walker AM, Lakshminaryan V, Shah R, Brandi ML, Ezzat S, Katsumata N, Friesen HG, Marx SJ, Eng J 1994 Circulating fibroblast growth factor-like autoantibodies in two patients with multiple endocrine neoplasia type I and prolactinoma. J Clin Endocrinol Metab 79:1546-1552
164. Schweigerer L, Neufeld G, Gospodarowicz D 1987 Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells. J Clin Invest 80:1516-1520
165. Atkin SL, Landolt AM, Jeffreys RV, Diver M, Radcliffe J, White MC 1993 Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation. J Clin Endocrinol Metab 77:831-837
166. Baird A, Mormed P, Ying SY, Wehrenberg WB, Ueno N, Ling N, Guillemin R 1985 A nonmitogenic pituitary function of fibroblast growth factor: regulation of thyrotropin and prolactin secretion. Proc Natl Acad Sci USA 82:5545-5549
167. Black EG, Logan A, Davis JRE, Sheppard MC 1990 Basic fibroblast growth factor affects DNA synthesis and cell function and activates multiple signalling pathways in rat thyroid FRTL-5 and pituitary GH3 cells. J Endocrinol 127:225-259
168. Mormede P, Baird A 1988 Estrogens, cyclic adenosine 3′,5′-monophosphate, and phorbol esters modulate the prolactin response of GH3 cells to basic fibroblast growth factor. Endocrinology 122: 2265-2271
169. Gonzalez AM, Logan A, Ying W, Lappi DA, Berry M, Baird A 1994 Fibroblast growth factor in the hypothalamic-pituitary axis: differential expression of fibroblast growth factor-2 and a high affinity receptor. Endocrinology 134:2289-2297
170. Larson GH, Koos RD, Sortino MA, Wise PM 1990 Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse haemolytic plaque assay. Endocrinology 126:927-932
171. Kasper S, Worsley IG, Rowe JM, Shiu RP, Friesen HG 1982 Chondrocyte growth factor from the human pituitary gland. J Biol Chem 257:5226-5230
172. Kasper S, Friesen HG 1986 Human pituitary tissue secretes a potent growth factor for chondrocyte proliferation. J Clin Endocrinol Metab 62:70-76
173. Sakamoto H, Mori M, Taira M, Yoshida T, Matsukawa S, Shimizu K, Sekiguchi
174. Basilico C, Newman KM, Curatola AM, Talarico D, Mansukhani A, Velcich A, Delli-Bovi P 1989 Expression and activation of the K-fgf oncogene. Ann NY Acad Sci 567:95-103
175. Shimon I, Huttner A, Said J, Spirina OM, Melmed S 1996 Heparin-binding secretory transforming gene (hst) facilitates rat lactotrope cell tumorigenesis and induces prolactin gene transcription. J Clin Invest 97:187-195
176. Gonsky R, Herman V, Melmed S, Fagin J 1991 Transforming DNA sequences present in human prolactin-secreting pituitary tumors. Mol Endocrinol 5:1687-1695
177. Levi-Montalcini R 1987 The nerve growth factor 35 years later. Science 237:1154-1162
178. Korsching S 1993 The neurotrophic factor concept: a reexamination. J Neurosci 13:2739-2748
179. Levi-Montalcini R, Dal Toso R, Della Valle F, Skaper F, Leon A 1995 Update of the NGF saga. J Neurol Sci 130:119-127
180. Saltiel AR, Decker SJ 1994 Cellular mechanism of signal transduction for neurotrophins. Bioessays 16:405-407
181. Chao MV, Hempstead BL 1995 p75 And Trk: a two-receptor system. Trends Neurosci 18:321-326
182. Barbacid M 1993 Nerve growth factor: a tale of two receptors. Oncogene 8:2033-2042
183. Tapley P, Lambelle F, Barbacid M 1992 K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors. Oncogene 7:371-381
184. Smeyne RJ, Klein R, Schnapp A, Long LK, Bryant S, Lewin A, Lira SA, Barbacid M 1994 Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 368:246-249
185. Muragaki Y, Timothy N, Leight S, Hempstead BL, Chao MV, Trojanowski JQ, Lee VM 1995 Expression of trk receptors in the developing and adult human central and peripheral nervous system. J Comp Neurol 365:387-397
186. Dobrowsky RT, Werner MH, Castellino AM, Chao MV, Hannun YA 1994 Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 265:1596-1599
187. Pennova N, Emiktapor G 1993 Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature 375: 68-73
188. Patterson JC, Childs GV 1994 Nerve growth factor and its receptor in the anterior pituitary. Endocrinology 135:1689-1696
189. Soinila S, Lakshmanan J, Lahtinen T 1988 Nerve growth factor like activity in the rat pituitary intermediate lobe. Neurosci Res 6:123-130
190. Lahtinen T, Soinila S, Lakshmanan J 1989 Biological demonstration of nerve growth factor in the rat pituitary gland. Neuroscience 30:164-170
191. Conner JM, Varon S 1993 Nerve growth factor immunoreactivity in the anterior pituitary of the rat. Neuroreport 4:395-398
192. Burnham P, Conner JM, Varon S 1995 Colocalisation of NGF and TSH like immunoreactivity in cultures of adult rat anterior pituitary cells. J Neurosci Res 41:73-78
193. Missale C, Boroni F, Sigala S, Buriani A, Fabris M, Leon A, Dal Toso R, Spano P 1996 Nerve growth factor in the anterior pituitary: localization in mammotroph cells and co-secretion with prolactin by a dopamine regulated mechanism. Proc Natl Acad Sci USA 93:4240-4250
194. Missale C, Boroni F, Frassine M, Caruso A, Spano P 1995 Nerve growth factor promotes the differentiation of pituitary mammotroph cells in vitro. Endocrinology 136:1205-1213
195. Borreli E, Sawchenko PE, Evans RM 1992 Pituitary hyperplasia induced by ectopic expression of nerve growth factor. Proc Natl Acad Sci USA 89:2764-2768
196. Missale C, Losa M, Boroni F, Giovanelli M, Balsari A, Spano PF 1995 Nerve growth factor and bromocriptine: a segmented therapy for human bromocriptine resistant prolactinomas. Br J Cancer 72: 1397-1399
197. Otten U, Baumann JB, Girard J 1979 Stimulation of the pituitary-adrenocortical axis by nerve growth factor. Nature 282:413-414
198. Taglialatela G, Angelucci L, Scaccianoce S, Foreman PJ, Perez-Polo JR 1991 Nerve growth factor modulates the activation of the hypothalamic-pituitary-adrenocorticoid axis by nerve growth factor. Nature 282:413-414
199. Taglialatela G, Angelucci L, Scaccianoce S, Foreman PJ, Perez-Polo JR 1991 Nerve growth factor modulates the activation of the hypothalamic-pituitary-adrenocortical axis during the stress response. Endocrinology 129:2212-2218
200. Scaccianoce S, Cigliana G, Nicolai R, Muscolo LA, Porcu A, Navarra D, Perez-Polo JR, Angelucci L 1993 Hypothalamic involvement in the activation of the pituitary-adrenocortical axis by nerve growth factor. Neuroendocrinology 58:202-209
201. Missale C, Boroni F, Losa M, Giovanelli M, Zanellato A, Dal Toso R, Balsari A, Spano PF 1993 Nerve growth factor suppresses the transforming phenotype of human prolactinomas. Proc Natl Acad Sci USA 90:7961-7965
202. Missale C, Losa M, Sigala S, Balsari A, Giovanelli M, Spano PF 1996 Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism. Mol Endocrinol 10:272-285
203. Takemoto K, Rokaeus A, Jornvall H, McDonald TJ, Matt V 1983 Galanin, a novel biological peptide from porcine intestine. FEBS Lett 164:124-128
204. Rokaeus A, Melander T, Hokfelt T, Lundberg JM, Tatemoto K, Carlquist M, Mutt V 1984 A galanin like peptide in the central nervous system and intestine of the rat. Neurosci Lett 42:161-166
205. Stofitch G, Jacobowitz DM 1985 Immunohistochemical mapping of galanin-like neurones in the rat central nervous system. Peptides 6:509-516
206. Skofitch G, Jacobowitz DM 1986 Quantitative distribution of galanin like immunoreactivity in the rat central nervous system. Peptides 7:609-613
207. Bennet WM, Hill SF, Ghatei MA, Bloom SR 1991 Galanin in the normal human pituitary and brain and in pituitary adenomas. J Endocrinol 130:463-467
208. Vrontakis ME, Sano T, Kovacs K, Friesen HG 1990 Presence of galanin-like immunoreactivity in nontumourous corticotrophs and corticotroph adenomas of the human pituitary. J Clin Endocrinol Metab 70:747-751
209. Steel JH, Gon G, O'Halloran DJ, Jones PM, Yanaihara N, Ishikawa H, Bloom SR, Polak JM 1989 Galanin and vasoactive intestinal polypeptide are co-localized with classical pituitary hormones and show plasticity of expression. Histochemistry 93:183-189
210. Maiter DM, Hooi SC, Koenig JI, Martin JB 1990 Galanin is a physiological regulator of spontaneous pulsatile secretion of growth hormone in the male rat. Endocrinology 126:1216-1222
211. Murakami Y, Kato Y, Shimatsu A, Koshiyama H, Hattori N, Yanaihara N, Imura H 1989 Possible mechanisms involved in growth hormone secretion induced by galanin in the rat. Endocrinology 124:1224-1229
212. Davis TME, Burrin JM, Bloom SR 1987 Growth hormone (GH) release in response to GH-releasing hormone in man is 3-fold enhanced by galanin. J Clin Endocrinol Metab 65:1248-1252
213. Wynick D, Hammond PJ, Akinsanya KO, Bloom SR 1993 Galanin regulates basal and estrogen-stimulated lactotroph function. Nature 364:529-532
214. Bauer FE, Ginsberg L, Venetikou M, MacKay DJ, Burrin JM, Bloom SR 1986 Growth hormone release in man induced by galanin, a new hypothalamic peptide. Lancet 2:192-194
215. Giustina A, Bodini C, Doga M, Schettino M, Pizzocolo G, Giustina G 1992 Galanin decreases circulating growth hormone levels in acromegaly. J Clin Endocrinol Metab 74:1296-1300
216. Giustina A, Licini M, Bussi AR, Girelli A, Pizzocolo G, Schettino M, Negro-Vilar A 1993 Effects of sex and age on the growth hormone response to galanin in healthy human subjects. J Clin Endocrinol Metab 76:1369-1372
217. Daughaday WH, Rotwein P 1989 Insulin-like growth factors I and II. Peptide, messenger RNA and gene structure, serum and tissue concentrations. Endocr Rev 10:68-91
218. D'Ercole AJ, Stiles AD, Underwood LE 1984 Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 81:935-939
219. Binoux M, Hossenlopp P, Lassarre C, Hardovin N 1981 Production of insulin-like growth factors and their carrier by rat pituitary gland and brain explants in culture. FEBS Lett 124:178-184
220. Fagin JA, Pixley S, Slanina S, Ong J, Melmed S 1987 Insulin-like growth factor I gene expression in GH3 rat pituitary cells: mRNA content, immunocytochemistry and secretion. Endocrinology 120: 2037-2043
221. Fagin S, Brown A, Melmed S 1988 Regulation of pituitary insulin-like growth factor I messenger ribonucleic acid levels in rats harbouring somatomammotrophic tumors: implications for growth hormone autoregulation. Endocrinology 122:2204-2210
222. Olchovsky D, Bruno JF, Gelato MC, Song J, Berelowitz M 1991 Pituitary insulin-like growth factor I content and gene expression in the streptozotoxin-diabetes rat: evidence for tissue-specific regulation. Endocrinology 128:923-928
223. Alberti VN, Takita LC, de Mesquita MI, Percario S, Maciel RM 1991 Immunohistochemical demonstration of insulin-like growth factor (IGF-I) in normal and pathological pituitary gland. Pathol Res Pract 187:541-542
224. Bach MA, Bondy CA 1992 Anatomy of the pituitary insulin-like growth factor system. Endocrinology 131:2588-2594
225. Thorner MO, Vance ML 1988 Growth hormone. J Clin Invest 82:745-747
226. Fagin JA, Fernandez-Mejia C, Melmed S 1989 Pituitary insulin-like growth factor-I gene expression: regulation by triiodothyronine and growth hormone. Endocrinology 125:2385-2391
227. Matsuo K, Yamashita S, Niwa M, Kurihara M, Harakawa S, Izumi M, Nagataki S, Melmed S 1990 Thyroid hormone regulates rat pituitary insulin-like growth factor-I receptors. Endocrinology 126: 550-554
228. Alberti VN, Takita LC, de Mesquita MIS, Percario S, Maciel RMB 1991 Immunohistochemical demonstration of insulin-like growth factor 1 (IGF-1) in normal and pathological human pituitary glands Pathol Res Pract 187:541-542
229. Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz RL 1981 Somatomedin C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 212:1279-1281
230. Brazeau P, Guillemin R, Ling N, van Wyk J, Humbel R 1982 Inhibition par les somatomedines de la secretion de l'hormone de croissance stimulee par le facteur hypothalamique somatocrinine (GRF) ou le peptide de synthese hpGRF. C R Seances Acad Sci III 295:651-654
231. Abe H, Molitch ME, Van Wyk JJ, Underwood LE 1983 Human growth hormone and somatomedin C suppress the spontaneous release of growth hormone in unanesthetized rats. Endocrinology 113:1319-1324
232. Tannenbaum GS, Guyda HJ, Posner BI 1983 Insulin-like growth factors: a role in growth hormone negative feedback and body weight regulation via brain. Science 220:77-79
233. Melmed S 1990 Acromegaly. N Engl J Med 322:966-977
234. Morita S, Yamashita S, Melmed S 1987 IGF-I action on rat anterior pituitary cells: effects of intracellular messengers on GH secretion and mRNA levels. Endocrinology 121:2000-2006
235. Yamashita S, Melmed S 1987a Insulin-like growth factor-I regulation of growth hormone gene transcription in primary rat pituitary cells. J Clin Invest 79:449-452
236. Yamashita S, Ong J, Melmed S 1987 Regulation of human GH gene expression by IGF-I in transfected cells. J Biol Chem 262:13254-13257
237. Ceda GP, Davis RG, Rosenfeld RG, Hoffman AR 1987 The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II. Endocrinology 120:1658-1662
238. Namba S, Morita S, Melmed S 1989 Insulin-like growth factor I action on growth hormone secretion and messenger ribonucleic acid levels: interactions with somatostatin. Endocrinology 124:1794-1799
239. Yamasaki H, Prager D, Melmed S 1993 Structure-function of the human IGF-I receptor: a discordance of somatotroph internalization and signaling. Mol Endocrinol 7:681-685
240. Prager D, Melmed S 1988 Insulin regulates expression of the human growth hormone gene in transfected cells. J Biol Chem 263: 16580-16585
241. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, LeBon T, Kathuria S, Chen E, Jacobs S, Francke U, Ramchandran J, Fujita-Yamaguchi Y 1986 Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that determine functional specificity. EMBO J 5:2503-2512
242. Rosenfeld RG, Ceda G, Wilson DM, Dollar LA, Hoffman AR 1984 Characterization of high-affinity receptors for insulin-like growth factors I and II on rat anterior pituitary cells. Endocrinology 114: 1571-1575
243. Rosenfeld RG, Ceda G, Cutler CW, Dollar LA, Hoffman AR 1985 Insulin and insulin-like growth factor (somatomedin) receptors on cloned rat pituitary tumor cells. Endocrinology 117:2008-2016
244. Goodyer CG, De Stephane L, Guyda HJ, Posner BI 1984 Effects of insulin-like growth factors on adult male rat pituitary function in tissue culture. Endocrinology 115:1568-1576
245. Yamasaki H, Prager D, Gebremedhin S, Moise L, Melmed S 1991 Binding and action of insulin-like growth factor I in pituitary tumor cells. Endocrinology 128:857-862
246. Yamamoto H, Prager D, Yamasaki H, Melmed S 1993 Rat pituitary GC cell insulin-like growth factor I receptor regulation. Endocrinology 133:1420-1425
247. Yamasaki H, Prager D, Gebremedhin S, Melmed S 1991a Insulin-like growth factor I attenuation of growth hormone is enhanced by over-expression of pituitary insulin-like growth factor I receptors. Mol Endocrinol 5:890-896
248. Yamasaki H, Prager D, Gebremedhin S, Melmed S 1992 Human insulin-like growth factor I receptor 950 tyrosine is required for somatotroph growth factor signal transduction. J Biol Chem 267: 20953-20958
249. Prager D, Yamasaki H, Weber M, Gebremedhin S, Melmed S 1992 Human IGF-I receptor function in pituitary growth hormone-secreting cells is suppressed by a dominant negative mutant. J Clin Invest 90:2117-2122
250. Webster J, Prager D, Melmed S 1994 Insulin-like growth factor-I activation of extracellular signal-related kinase 1 and 2 in growth hormone-secreting cells. Mol Endocrinol 8:539-544
251. Melmed S, Yamashita S, Yamasaki H, Fagin J, Namba H, Yamamoto H, Weber M, Morita S, Webster J, Prager D 1996 IGF-I receptor signalling: lessons from the somatotroph. Recent Prog Horm Res 51:189-216
252. Greenman Y, Prager D, Melmed S 1994 IGF-I receptor sub-membrane is intact in GH-secreting pituitary tumors. Clin Endocrinol (Oxf) 42:169-172
253. Yamashita S, Weiss M, Melmed S 1986 insulin-like growth factor I regulates growth hormone secretion and messenger RNA levels in human pituitary tumor cells. J Clin Endocrinol Metab 63:730-735
254. Guler H-P, Wettstein K, Schurr W, Zapf J, Froesch ER 1991 Recombinant human insulin-like growth factor I: effects in normal subjects and implications for use in patients. In: Raizada MK, Le-Roith D (eds) Molecular Biology and Physiology of Insulin and Insulin-like Growth Factors. Adv Exp Med Biol 293:97-104
255. Hartman ML, Clayton PE, Johnson ML, Celniker A, Perlman AJ, Alberti KG, Thorner MO 1993 A low-dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J Clin Invest 91:2453-2462
256. Bermann M, Jaffe CA, Tsai W, DeMott-Friberg R, Barkan AL 1994 Negative feedback regulation of putative growth growth hormone secretion by insulin-like growth factor I. Involvement of hypothalamic somatostatin. J Clin Invest 94:138-145
257. Ho KY, Veldhuis JO, Johnson ML, Furlanetto R, Evans WS, Alberti KG, Thorner MO 1988 Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest 81:968-975
258. Weber MM, Melmed S, Rosenbloom J, Yamasaki H, Prager D 1992 Rat somatotroph insulin-like growth factor II signalling: role of the insulin-like growth factor I receptor. Endocrinology 131: 2147-2153
259. Harel Z, Tannenbaum GS 1992 Synergistic interaction between insulin-like growth factors I and II in central regulation of pulsatile GH secretion. Endocrinology 131:758-764
260. Massague J, Polyak K 1995 Mammalian antiproliferative signals and their targets. Curr Opin Genet Dev 5:91-96
261. Jakowlew SB, Dilard PJ, Kondaiah P, Sporn MB, Roberts AB 1988 Complementary deoxyribonucleic acid cloning of a novel transforming growth factor-beta messenger ribonucleic acid from chick embryo chondrocytes. Mol Endocrinol 2:747-755
262. Derynck R, Lindquist PB, Lee A, Wen D, Tamm J, Graycar JL, Rhee L, Mason AJ, Miller DA, Coffey RJ 1988 A new type of transforming growth factor-beta, TGF-beta 3. EMBO J 7:3737-3743
263. Jakowlew SB, Dillard PJ, Sporn MB, Roberts AB 1988 Complementary deoxyribonucleic acid cloning of a messenger ribonucleic acid encoding transforming growth factor beta 4 from chicken embryo chondrocytes. Mol Endocrinol 2:1186-1195
264. Kondaiah P, Sands MJ, Smith JM, Fields A, Roberts AB, Sporn MB, Melton DA 1990 Identification of a novel transforming growth factor-beta (TGF-beta5) mRNA in Xenopus laevis. J Biol Chem 265: 1089-1093
265. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV 1985 Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 316:701-705
266. Roberts AB, Sporn MB 1993 Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors 8:1-9
267. Sarkar DK, Kim KH, Minami S 1992 Transforming growth factor β 1 messenger RNA and protein expression in the pituitary gland: its action on prolactin secretion and lactotrophic growth. Mol Endocrinol 6:1825-1833
268. Sarkar DK, Kim KH, Minami S 1992 Transforming growth factor beta 1 messenger RNA and protein expression in the pituitary gland: its action on prolactin secretion and lactotrophic growth. Mol Endocrinol 6:1825-1833
269. Pastorcic M, De A, Boyadjieva N, Vale W, Sarkar DK 1995 Reduction in the expression and action of transforming growth factor beta-1 lactotrophs during estrogen-induced tumorigenesis in the anterior pituitary. Cancer Res 55:4892-4898
270. Burns G, Sarkar DK 1993 Transforming growth factor beta 1 like immunoreactivity in the pituitary gland of the rat: effect of estrogen. Endocrinology 133:1444-1449
271. Albaladejo V, Fei ZL, Nicolas B, Joly-Pharaboz MO, Avallet O, Vigier M, Andre J 1992 Possible involvement of transforming growth factor beta in the inhibition of rat pituitary tumor growth by estradiol. J Steroid Biochem Mol Biol 41:125-134
272. Laiho M, Weiss FM, Boyd FT, Ignotz RA, Massague J 1991 Responsiveness to transforming growth factor-beta (TGF-beta) restored by genetic complementation between cells defective in TGF-beta receptors I and II. J Biol Chem 266:9108-9112
273. Boyd FT, Massague J 1989 Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53 kDa membrane receptor. J Biol Chem 264:2272-2278
274. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massague J 1992 TGF beta signals through a heterodimeric protein kinase receptor complex. Cell 71:1003-1014
275. Lopez-Casilas F, Wrana JL, Massague J 1993 Betaglycal presents ligand to the TGF beta signalling receptor. Cell 73:1435-1444
276. Cheifetz S, Ling N, Guillemin R, Massague J 1988 A surface component on GH3 pituitary cells that recognises transforming growth factor-beta, activin and inhibin. J Biol Chem 263:17225-17228
277. Alexander JM, Bikkal HA, Zervas NT, Laws Jr ER, Klibanski A 1996 Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-B receptors in human pituitary adenomas. J Clin Endocrinol Metab 81:783-790
278. Serra R, Moses HL 1996 Tumor suppressor genes in the TGF b signalling pathway? Nature Med 2:390-391
279. Serra R, Moses HL 1995 pRb is necessary for inhibition of N-Myc expression by TGF b1 in embryonic lung organ culture. Development 121:3057-3066
280. Alexandrow MG, Moses HL 1995 Transforming growth factor beta and cell cycle regulation. Cancer Res 55:1452-1457
281. Hannon GJ, Beach D 1994 p15INK4B is a potential effector of TGF beta induced cell cycle arrest. Nature 371:257-261
282. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massague J 1990 Growth inhibition by TGF β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175-185
283. Cobrinik D, Dowdy SF, Hinds PW, Mittnacht S, Weinberg RA 1992 The retinoblastoma protein and the regulation of cell cycling. Trends Biochem Sci 17:312-315
284. Qian X, Ju L, Grande JP, Lloyd RV 1996 Transforming growth factor beta and p27 expression in pituitary cells. Endocrinology 137:3051-3060
285. Ramsdell JS 1991 Transforming growth factor alpha and beta are potent and effective inhibitors of GH4 pituitary rumor cell proliferation Endocrinology 128:1981-1990
286. Sarkar DK, Kim KH, Minami S 1992 Transforming growth factor β 1 messenger RNA and protein expression in the pituitary gland: its action on prolactin secretion and lactotrophic growth. Mol Endocrinol 6:1825-1833
287. Delidow BC, Billis WM, Agarwal P, White BA 1991 Inhibition of prolactin gene transcription by TGF β in GH3 cells. Mol Endocrinol 5:1716-1722
288. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A 1994 p27KIP, a cyclin-cdk inhibitor, links transforming growth factor beta and contact inhibition to cell cycle arrest. Genes Dev 8:9-22
289. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY, Nakayama K-I 1996 Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors. Cell 85:707-720
290. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A 1996 Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85:721-732
291. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, Kaushansky K, Roberts JM 1996 A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis and female sterility in p27(Kip1)-deficient mice. Cell 85:733-744
292. Kaiser UB, Lee BL, Carroll RS, Unabia G, Chin WW, Childs GV 1992 Follistatin gene expression in the pituitary: localization in gonadotroph and folliculostellate cells in diestrous rats. Endocrinology 130:3048-3056
293. Meunier H, Rivier C, Evans RM, Vale W 1988 Gonadal and extragonadal expression of inhibin alpha, beta A and beta B subunits in various tissues predicts diverse functions. Proc Natl Acad Sci USA 85:247-251
294. Roberts V, Meunier H, Vaughan J, Rivier J, Rivier C, Vale W, Sawchenko P 1988 Production and regulation of inhibin subunits in pituitary gonadotropes. Endocrinology 124:552-554
295. Billestrup N, Gonzalez-Manchon C, Potter E, Vale W 1990 Inhibition of somatotroph growth and growth hormone biosynthesis by activin in vitro. Mol Endocrinol 4:356-362
296. Bilezekian LM, Blount AL, Campen CA, Gonzalez-Manchon C, Vale W 1991 Activin A inhibits proopiomelanocortin messenger RNA accumulation and adrenocorticotropin secretion of AtT20 cells. Mol Endocrinol 5:1389-13985
297. Kitaoka M, Kojima I, Ogata E 1988 Activin A: a modulator of multiple types of anterior pituitary cells. Biochem Biophys Res Commun 157:48-54
298. Campos RV, Asa SL, Drucker DJ 1991 Immunocytochemical localization of parathyroid-hormone like peptide in rat fetus. Cancer Res 51:6351-6357
299. Mangin M, Ikeda K, Dreyer BE, Broadus AE 1989 Isolation and characterization of the human parathyroid-hormone-like peptide gene. Proc Natl Acad Sci USA 86:2408-2412
300. Urena P, Kong XF, Abou-Samra A, Juppner H, Kronenberg HM, Potts Jr JT, Segre GV 1993 Parathyroid hormone (PTH)/PTH-related peptide messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology 133:617-623
301. Yamashita S, Akino K, Ohtsuru A 1996 Role of parathyroid hormone related peptide in the pathogenesis of pituitary adenomas. In: Melmed S (ed) Frontiers in Hormone Research. Basel, Karger, vol 20:138
302. Akino K, Ohtsura A, Yano H, Ozeki S, Namba H, Nakashima M, Ito M, Matsumoto T, Yamashita S 1996 Antisense inhibition of parathyroid hormone-related peptide gene expression reduces malignant pituitary tumor progression and metastases in the rat. Cancer Res 56:77-86
303. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A 1987 Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330: 662-664
304. Koike K, Hirota K, Ohmichi M, Kadowaki K, Ikegami H, Yamaguchi M, Miyake A, Tanizawa O 1991 Tumor necrosis factor alpha increases release of arachidonate and prolactin from rat anterior pituitary cells. Endocrinology 128:2791-2798
305. Koike K, Masumoto N, Kasahara K, Yamaguchi M, Tasaka K, Hirota K, Miyake A, Tanizawa O 1991 Tumor necrosis factor alpha stimulates prolactin release from anterior pituitary cells: a possible involvement of intracellular calcium mobilization. Endocrinology 128:2785-2790
306. Milenkovic L, Rettori V, Snyder GD, Beutler B, McCarr SM 1989 Cachectin alter anterior pituitary hormone release by a direct action in vitro. Proc Natl Acad Sci USA 86:2418-2422
307. Gaillard RC, Turnill D, Sappino P, Muller AF 1990 Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. Endocrinology 127:101-106
308. Bernardini R, Kamilaris TC, Calogero AE, Johnson EO, Gomez MT, Gold PW, Chrousos GP 1990 Interactions between tumor necrosis factor alpha, hypothalamic corticotropin-releasing hormone and adrenocorticotropin secretion in the rat. Endocrinology 126:2876-2881
309. Bauer TW, Moriarty CM, Childs GV 1981 Studies of immunoreactive gonadotropin hormone releasing hormone (GnRH) the rat anterior pituitary. J Histochem Cytochem 26:901-908
310. May V, Wilber JF, U'Pritchard DC, Childs GV 1987 Persistance of immunoreactive thyrotropin-releasing hormone and GnRH in long-term primary anterior pituitary cultures. Peptides 8:543-558
311. Childs GV, Cole DE, Kubek M, Tobin RB, Wilber JF 1978 Endogenous TRH in the anterior pituitary: sites of activity as identified by immunocytochemical staining. J Histochem Cytochem 26:901-908
312. Levy A, Lightman SL 1992 Growth hormone-releasing hormone transcripts in human pituitary adenomas. J Clin Endocrinol Metab 74:1474-1476
313. Levy L, Bourdais J, Mouhieddine B, Benlot C, Villares S, Cohen P, Peillon F, Joubert D 1993 Presence and characterization of the somatostatin precursor in normal human pituitaries and in growth hormone secreting adenomas. J Clin Endocrinol Metab 76:85-90
314. Morel G, Henning F, Toron MC, Mesguich P, Dubois, MP, Dubois PM 1983 Ultrastructural evidence for endogenous somatostatin-like immunoreactivity in the pituitary gland. Neuroendocrinology 36:291-299
315. Sternberger LA, Petrali JP, Joseph SA, Meyer HG, Mills KR 1978 Specificity of the immunocytochemical leutenizing hormone-releasing hormone receptor reaction. Endocrinology 102:63-73
316. Pollock DM, Keith TL, Highsmith RF 1995 Endothelin receptors and calcium signalling. FASEB J 9:1196-1204
317. Vierhapper H 1996 Effect of endothelin I in man-impact on basal and stimulated concentrations of luteinizing hormone, follicle-stimulating hormone, thyrotropin, growth hormone, corticotropin, and prolactin with and without pretreatment with nifedipine. Metabolism 45:658-661
318. Levy H, Gabon R, Bdolak A, Sokolovsky M, Naor Z 1992 Paradoxical signal transduction mechanism of endothelin and safarotoxin in cultured pituitary cells: stimulation of phosphoinositide turnover and inhibition of prolactin release. Mol Cell Endocrinol 89:1-9
319. Samson WK, Skala KD, Alexander BD, Huang F-LS 1990 Pituitary site of action of endothelin: selective inhibition of prolactin release in vitro. Biochem Biophys Res Commun 169:737-743
320. Burris TP, Kayicska B, Freeman ME 1991 Inhibition of prolactin secretion by endothelin-3 is pertussis toxin-sensitive. Eur J Pharmacol 198:223-225
321. Stojilkovic SS, Balla T, Fukuda S, Cesnjaj M, Merelli F, Krsmanovic LZ, Catt KJ 1992 Endothelin ETA receptors mediate the signalling and secretory actions of endothelin in pituitary gonadotrophs. Endocrinology 130:465-474
322. Kanyicska B, Burris TB, Freeman ME 1991 Endothelin-3 inhibits prolactin and stimulates LH, FSH and TSH secretion from pituitary cell culture. Biochem Biophys Res Commun 174:338-343
323. Takahashi K, Ghatei MA, Jones PM, Murphy JK, Lam HC, O'Halloran DJ, Bloom SR 1991 Endothelin in human brain and pituitary gland: presence of immunoreactive endothelin, endothelin messenger ribonucleic acid, and endothelin receptors. J Clin Endocrinol Metab 72:693-699
324. Matsumoto H, Suzuki N, Orda H, Fujino M 1989 Abundance of endothelin 3 in rat intestine, pituitary gland and brain. Biochem Biophys Res Commun 164:74-80
325. Wu-Wong JR, Chiou WJ, Dixon DB, Opgenorth TJ 1995 Dissociation characteristics of endothelin ETA receptor agonists and antagonists. J Cardiovasc Pharmacol 265:380-384
326. Steele MK, Brownfield MS, Ganong WF 1982 Immunocytochemical localization of angiotensin 11 immunoreactivity in gonadotropes and lactotropes of the rat anterior pituitary gland. Neuroendocrinology 35:155-158, 1982
327. Steele MK, Negro-Vilar A, McCann SM 1981 Effect of angtiotensin II on in vivo and in vitro release of anterior pituitary hormones in the female rat. Endocrinology 109:893-899
328. Naruse K, Takii Y, Inagami T 1981 Immunohistochemical localization of renin in luteinizing hormone-producing cells of rat pituitary. Proc Natl Acad Sci USA 78:7579-7583
329. Robberecht W, Denef C 1988 Stimulation and inhibition of pituitary growth hormone release by angiotensin II in vitro. Endocrinology 122:1496-1504
330. Spinedi E, Negro-Vilar A 1983 Angiotensin II and ACTH release: site of action and potency relative to corticotropin releasing factor and vasopressin. Neuroendocrinology 37:446-453
331. Herman V, Fagin J, Gonsky R, Kovacs K, Melmed S 1990 Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 71:1427-1433
332. Alexander JM, Biller BM, Bikkal H, Zervas NT, Arnold A, Klibanski A 1990 Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest 86:336-340
333. Rogelj S, Weinberg RA, Fanning P, Klagsbrun M 1988 Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature 331:173-175
334. Burgess WH, Maciag T 1989 The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 58:575-606
335. Browder TM, Abrams JS, Wong PM, Neinhuis AW 1989 Mechanism of autocrine stimulation in hematopoietic cells producing interleukin 3 after retrovirus-mediated gene transfer. Mol Cell Biol 9:204-213
336. s and stimulate adenylyl cyclase in human pituitary tumors. Nature 340: 692-696
337. Cai WY, Alexander JM, Hedley-Whyte ET, Scheithauer BW, Jameson JL, Zervas NT, Klibanski A 1994 Ras mutations in human prolactinomas and pituitary carcinomas. J Clin Endocrinol Metab 78:89-93
338. Pei L, Melmed S, Scheithauer B, Kovacs K, Prager D 1994 H-ras mutations in human pituitary carcinoma metastases. J Clin Endocrinol Metab 78:842-846
339. Herman V, Drazin NZ, Gonsky R, Melmed S 1993 Molecular screening of pituitary adenomas for gene mutations and rearrangements. J Clin Endocrinol Metab 77:50-55
340. Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF, Prager D 1995 Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res 55:1613-1616
341. Melmed S, Ho K, Thorner M, Klibanski A, Reichlin S 1995 Recent advances in the pathogenesis, diagnosis and management of acromegaly. J Clin Endocrinol Metab 80:3395-3402
342. Bone RC 1991 The pathogenesis of sepsis. Ann Intern Med 115: 457-469
343. Hesse DG, Tracey KJ, Fong Y, Manogue KR, Palladino Jr MA, Cerami A, Shires GT, Lowry SF 1988 Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 166:147-153
344. Van Deveter SJH, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A 1990 Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrolytic and complement pathways. Blood 76:2500-2526
345. Chrousos GP 1995 The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:1351-1362
346. Almawi WY, Lupman ML, Stevens AR, Zanker B, Hadro ET, Strom TB 1991 Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic actions of IL-6 and IFN-gamma. J Immunol 146:3523-3527
347. Kam JC, Szeffer SJ, Surs W, Sher ER, Leung DYM 1993 Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 151:3460-3466
348. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin Jr AS 1995
349. Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, Van der Saag PT 1995 Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the anti-inflammatory action of glucocorticoids. Mol Endocrinol 9:401-412
350. Ray A, Prefontaine KE 1994 Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 91:752-756
351. Waring PM, Waring LJ, Bellington T, Metcalf D 1995 Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice. Proc Natl Acad Sci USA 92:1337-1341
352. Muglia L, Jacobson L, Dikkes P, Majzoub JA 1995 Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 373:427-432
353. Fattori E, Sellito C, Cappelletti M, Lazzaro D, Bellavia D, Screpanti I, Gulino A, Costantini F, Poli V 1995 Functional analysis of IL-6 and IL-DBP/C/EBP beta by gene targeting. Ann NY Acad Sci 762:262-273
354. Kopf M, Ramsay A, Brombacher F, Baumann H, Freer G, Galanos C, Gutierrez-Ramos JC, Kohler G 1995 Pleiotropic defects of IL-6 deficient mice including early hematopoiesis, T and B cell function, and acute phase responses. Ann NY Acad Sci 762:308-318
355. Bluethmann H, Rothe J, Schultze N, Tkachuk M, Koebel P 1994 Establishment of the role of IL-6 and TNF receptor I using gene knockout mice. J Leukoc Biol 56:565-570
356. Libert C, Takahashi N, Cauwels A, Brouckaert P, Bluethmann H, Fiers W 1994 Response of interleukin-6-deficient mice to tumor necrosis factor-induced. Eur J Immunol 24:2237-2242
357. Melmed S 1997 Molecular basis of pituitary function and neoplasia. In: Jameson JL (ed) Textbook of Molecular Medicine. Blackwell Scientific Press, Boston